APA (7th ed.) Citation

S, S., A, I., ML, C., J, N., B, V. H., J, T., . . . D, P. (2022). Doravirine Concentrations and Human Immunodeficiency Virus Type 1 RNA in the Genital Fluids of Virologically Suppressed Adults Switching to Doravirine Plus Emtricitabine/Tenofovir Alafenamide. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 75(11), 2012. https://doi.org/10.1093/cid/ciac410

Chicago Style (17th ed.) Citation

S, Scévola, et al. "Doravirine Concentrations and Human Immunodeficiency Virus Type 1 RNA in the Genital Fluids of Virologically Suppressed Adults Switching to Doravirine Plus Emtricitabine/Tenofovir Alafenamide." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 75, no. 11 (2022): 2012. https://doi.org/10.1093/cid/ciac410.

MLA (9th ed.) Citation

S, Scévola, et al. "Doravirine Concentrations and Human Immunodeficiency Virus Type 1 RNA in the Genital Fluids of Virologically Suppressed Adults Switching to Doravirine Plus Emtricitabine/Tenofovir Alafenamide." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 75, no. 11, 2022, p. 2012, https://doi.org/10.1093/cid/ciac410.